| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,832 |
3,348 |
$319K |
| 80053 |
Comprehensive metabolic panel |
3,719 |
3,227 |
$244K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,735 |
3,895 |
$194K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
986 |
828 |
$183K |
| 36415 |
Collection of venous blood by venipuncture |
4,661 |
3,934 |
$140K |
| J3490 |
Unclassified drugs |
1,536 |
664 |
$115K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
239 |
191 |
$103K |
| 81003 |
|
2,226 |
1,949 |
$96K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
641 |
507 |
$95K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,704 |
1,568 |
$89K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
94 |
78 |
$88K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
858 |
261 |
$81K |
| 80061 |
Lipid panel |
1,231 |
1,171 |
$78K |
| 71046 |
Radiologic examination, chest; 2 views |
1,132 |
988 |
$77K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
84 |
66 |
$75K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,176 |
904 |
$66K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
832 |
765 |
$59K |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
445 |
280 |
$57K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
552 |
408 |
$51K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,181 |
950 |
$51K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
403 |
346 |
$50K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
782 |
622 |
$48K |
| 87088 |
|
728 |
620 |
$45K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
683 |
640 |
$37K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
291 |
213 |
$36K |
| 70450 |
Computed tomography, head or brain; without contrast material |
251 |
221 |
$35K |
| 83690 |
|
477 |
379 |
$32K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
198 |
130 |
$31K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
360 |
237 |
$30K |
| 87077 |
|
468 |
380 |
$28K |
| 84484 |
|
714 |
571 |
$25K |
| 81025 |
|
219 |
170 |
$24K |
| 87186 |
|
399 |
325 |
$24K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
318 |
213 |
$22K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
214 |
203 |
$22K |
| 84703 |
|
204 |
176 |
$21K |
| 80306 |
|
231 |
205 |
$20K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
502 |
367 |
$20K |
| 87400 |
|
362 |
296 |
$17K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
74 |
71 |
$16K |
| 82553 |
|
451 |
364 |
$15K |
| 82550 |
|
530 |
423 |
$15K |
| 83735 |
|
476 |
395 |
$15K |
| 71045 |
Radiologic examination, chest; single view |
304 |
257 |
$14K |
| 83615 |
|
425 |
346 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
251 |
216 |
$12K |
| 85610 |
|
562 |
380 |
$12K |
| 82150 |
|
138 |
119 |
$8K |
| 85730 |
|
233 |
200 |
$7K |
| 87081 |
|
135 |
113 |
$7K |
| 82948 |
|
57 |
39 |
$6K |
| 87040 |
|
70 |
53 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
37 |
36 |
$5K |
| 73630 |
|
85 |
79 |
$4K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
12 |
12 |
$3K |
| 73560 |
|
49 |
40 |
$3K |
| 83605 |
|
62 |
56 |
$3K |
| 84100 |
|
93 |
83 |
$3K |
| 82607 |
|
46 |
44 |
$3K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
52 |
28 |
$3K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
42 |
40 |
$2K |
| 73610 |
|
36 |
28 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
22 |
21 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
41 |
29 |
$1K |
| 82043 |
|
27 |
25 |
$1K |
| 97161 |
|
18 |
17 |
$947.99 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
18 |
16 |
$822.18 |
| 85379 |
|
17 |
16 |
$805.39 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17 |
13 |
$625.02 |
| 74022 |
|
13 |
12 |
$395.77 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
28 |
14 |
$51.34 |
| T1015 |
Clinic visit/encounter, all-inclusive |
30 |
26 |
$0.00 |